# A Study of PM1015 in Patients With Advanced Solid Tumors

> **NCT05950815** · PHASE1 · UNKNOWN · sponsor: **Biotheus Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** CD73 Antigen

## Key facts

- **NCT ID:** NCT05950815
- **Lead sponsor:** Biotheus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-10
- **Primary completion:** 2023-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05950815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05950815, "A Study of PM1015 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05950815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*